Share Price | Fujian Wanchen Biotechnology Group Co., Ltd. Stock Analysis & Recommendation

Results Declared: Fujian Wanchen Biotechnology Group Co., Ltd. has declared results on 17 Mar 2026! Click here to unlock the latest financial performance

Mojo Score Change: Fujian Wanchen Biotechnology Group Co., Ltd. has changed its score on 17 Mar 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a growth in Net Profit of 361.22%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 2,258.65 MM
INTEREST COVERAGE RATIO(Q) Highest at 7,500.77
ROCE(HY) Highest at 72.05%

Consistent Returns over the last 3 years

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CNY 32,398 Million (Large Cap)

P/E

25.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.44

Return on Equity

90.58%

Price to Book

15.87

Revenue and Profits:

Net Sales:

14,897 Million

(Quarterly Results - Dec 2025)

Net Profit:

833 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

3.87%

6 Months

14.72%

1 Year

138.21%

2 Years

531.97%

3 Years

498.44%

4 Years

1124.67%

5 Years

0.0%

Fujian Wanchen Biotechnology Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

240.59%

EBIT Growth (5y)

267.09%

EBIT to Interest (avg)

9.86

Debt to EBITDA (avg)

0.40

Net Debt to Equity (avg)

-1.12

Sales to Capital Employed (avg)

9.53

Tax Ratio

36.09%

Dividend Payout Ratio

35.00%

Pledged Shares

Institutional Holding

ROCE (avg)

8.42%

ROE (avg)

20.88%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

20.24

EV to EBIT

16.33

EV to EBITDA

14.14

EV to Capital Employed

-88.14

EV to Sales

0.70

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

81.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 27.15% vs 166.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 222.16% vs 2,880.65% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,896.80",
          "val2": "11,715.70",
          "chgp": "27.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,138.00",
          "val2": "473.00",
          "chgp": "140.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.40",
          "val2": "14.00",
          "chgp": "-11.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "833.10",
          "val2": "258.60",
          "chgp": "222.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.00%",
          "val2": "34.40%",
          "chgp": "3.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 59.08% vs 247.83% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 301.77% vs 513.22% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51,378.80",
          "val2": "32,296.50",
          "chgp": "59.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,430.20",
          "val2": "1,263.80",
          "chgp": "171.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "55.30",
          "val2": "53.30",
          "chgp": "3.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,423.90",
          "val2": "603.30",
          "chgp": "301.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.30%",
          "val2": "30.40%",
          "chgp": "3.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

14,896.80

11,715.70

27.15%

Operating Profit (PBDIT) excl Other Income

1,138.00

473.00

140.59%

Interest

12.40

14.00

-11.43%

Exceptional Items

0.00

Consolidate Net Profit

833.10

258.60

222.16%

Operating Profit Margin (Excl OI)

72.00%

34.40%

3.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 27.15% vs 166.67% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 222.16% vs 2,880.65% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

51,378.80

32,296.50

59.08%

Operating Profit (PBDIT) excl Other Income

3,430.20

1,263.80

171.42%

Interest

55.30

53.30

3.75%

Exceptional Items

-10.70

0.00

Consolidate Net Profit

2,423.90

603.30

301.77%

Operating Profit Margin (Excl OI)

61.30%

30.40%

3.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 59.08% vs 247.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 301.77% vs 513.22% in Dec 2024

All Annual Results

Company CV

About Fujian Wanchen Biotechnology Group Co., Ltd.

Fujian Wanchen Biotechnology Group Co., Ltd.

Other Agricultural Products

No Details Available.

Company Coordinates

No Company Details Available